United Therapeutics Corporation: accounts_receivable
| Value | {"amount": 312000000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | United Therapeutics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:44:48.732428+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2bd5d5f1-36c9-411c-92d8-f1574f55a32c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001082554-26-000020Retrieved: 2026-08-19T10:44:48.732428+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001082554/accounts-receivable/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2bd5d5f1-36c9-411c-92d8-f1574f55a32c
History
- no predecessors — first report